NovaXS Biotech Corp, developers of an in-home and needle-free drug delivery platform, has unveiled a new prototype of its needle-free injection therapy smart medical device. The team presented it at mHub’s MedTech Accelerator Program’s annual Demo Day in Chicago.
Jonathan Xing, COO and co-founder of NovaXS, along with Alex Zou, the chief technology officer of NovaXS showcased the new prototype.
The patent-pending technology called Telosis administers a narrow stream of medication without a needle in 0.3 seconds and analyzes injection data to help users make smarter health decisions.
It’s the world’s first remote medication and self-administration monitoring platform and provides an easy and painless alternative for at-home drug delivery. The first indication NovaXS is pursuing is IVF treatments.
#Needle-free #Biotech #NovaXS #IVF_Treatment
Article By: Charles Sternberg
To read to the full article please go to: